Medipower (Overseas) Public Co. Limited

TASE:MDPR 주식 보고서

시가총액: ₪263.5m

Medipower (Overseas) 미래 성장

Future 기준 확인 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Medipower (Overseas).

주요 정보

n/a

수익 성장률

n/a

EPS 성장률

Real Estate 수익 성장21.2%
매출 성장률n/a
향후 자기자본 수익률n/a
애널리스트 커버리지

None

마지막 업데이트n/a

최근 미래 성장 업데이트

업데이트 없음

Recent updates

Solid Earnings Reflect Medipower (Overseas)'s (TLV:MDPR) Strength As A Business

Mar 29
Solid Earnings Reflect Medipower (Overseas)'s (TLV:MDPR) Strength As A Business

Medipower (Overseas) Public Co. Limited's (TLV:MDPR) Business Is Yet to Catch Up With Its Share Price

Jan 31
Medipower (Overseas) Public Co. Limited's (TLV:MDPR) Business Is Yet to Catch Up With Its Share Price

A Look At The Intrinsic Value Of Medipower (Overseas) Public Co. Limited (TLV:MDPR)

May 06
A Look At The Intrinsic Value Of Medipower (Overseas) Public Co. Limited (TLV:MDPR)

If You Had Bought Medipower (Overseas) (TLV:MDPR) Stock Three Years Ago, You Could Pocket A 25% Gain Today

Jan 25
If You Had Bought Medipower (Overseas) (TLV:MDPR) Stock Three Years Ago, You Could Pocket A 25% Gain Today

With A 4.7% Return On Equity, Is Medipower (Overseas) Public Co. Limited (TLV:MDPR) A Quality Stock?

Dec 16
With A 4.7% Return On Equity, Is Medipower (Overseas) Public Co. Limited (TLV:MDPR) A Quality Stock?

이 섹션에서는 일반적으로 투자자가 회사의 수익 창출 능력을 이해하는 데 도움이 되도록 전문 애널리스트의 컨센서스 추정치를 기반으로 수익 및 수익 성장 전망치를 제시합니다. 하지만 Medipower (Overseas) 은 충분한 과거 데이터를 제공하지 않았고 애널리스트 예측도 없기 때문에 과거 데이터를 추정하거나 애널리스트 예측을 사용하여 미래 수익을 안정적으로 계산할 수 없습니다.

SimplyWall St에서 다루는 기업의 97%가 과거 재무 데이터를 가지고 있기 때문에 이는 매우 드문 상황입니다.

수익 및 매출 성장 예측

TASE:MDPR - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
6/30/20243981515N/A
3/31/20243981414N/A
12/31/20233981212N/A
9/30/20233831313N/A
6/30/20233841414N/A
3/31/20233851313N/A
12/31/20223811313N/A
9/30/202237121111N/A
6/30/20223791111N/A
3/31/20223451010N/A
12/31/20213191010N/A
9/30/202127299N/A
6/30/202124499N/A
3/31/202124488N/A
12/31/202024388N/A
9/30/202023477N/A
6/30/202022488N/A
3/31/202020488N/A
12/31/201919477N/A
9/30/201919677N/A
6/30/201919666N/A
3/31/201919566N/A
12/31/201819555N/A
9/30/201819555N/A
6/30/201818555N/A
3/31/2018174N/A4N/A
12/31/2017155N/A4N/A
9/30/2017142N/A3N/A
6/30/2017143N/A3N/A
3/31/2017133N/A3N/A
12/31/2016122N/A4N/A
9/30/2016112N/A3N/A
6/30/2016110N/A3N/A
3/31/2016110N/A1N/A
12/31/201512-1N/A1N/A
9/30/201513-1N/A1N/A
6/30/2015140N/A1N/A
3/31/201514-1N/A2N/A
12/31/201414-1N/A1N/A
9/30/2014147N/A1N/A
6/30/2014147N/A1N/A
3/31/2014146N/A1N/A
12/31/2013146N/A1N/A

애널리스트 미래 성장 예측

수입 대 저축률: Insufficient data to determine if MDPR's forecast earnings growth is above the savings rate (2.3%).

수익 vs 시장: Insufficient data to determine if MDPR's earnings are forecast to grow faster than the IL market

고성장 수익: Insufficient data to determine if MDPR's earnings are expected to grow significantly over the next 3 years.

수익 대 시장: Insufficient data to determine if MDPR's revenue is forecast to grow faster than the IL market.

고성장 수익: Insufficient data to determine if MDPR's revenue is forecast to grow faster than 20% per year.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: Insufficient data to determine if MDPR's Return on Equity is forecast to be high in 3 years time


성장 기업 발견